Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.


  • Enzo Biochem, Inc. (NYSE:ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
  • Histogen Inc. (NASDAQ:HSTO) climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use.
  • QualTek Services Inc. (NASDAQ:QTEK) gained 56.4% to $0.4379. QualTek secured new money financing.
  • AirNet Technology Inc. (NASDAQ:ANTE) climbed 38.3% to $1.12.
  • Maxpro Capital Acquisition Corp. (NASDAQ:JMAC) gained 38% to $13.66.
  • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) jumped 28% to $1.25.
  • Traeger, Inc. (NYSE:COOK) gained 24% to $3.7415 after the company announced better-than-expected Q4 results.
  • AppTech Payments Corp. (NASDAQ:APCX) jumped 22.8% to $1.5350.
  • Aclarion, Inc. (NASDAQ:ACON) gained 20% to $0.83.
  • Berkshire Grey, Inc. (NASDAQ:BGRY) climbed 18.3% to $1.16.
  • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) jumped 18% to $15.98
  • Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) gained 18% to $4.63.
  • Boqii Holding Limited (NYSE:BQ) gained 15.7% to $1.10.
  • Orla Mining Ltd. (NYSE:ORLA) climbed 13.7% to $4.55 after the company reported Q4 EPS results were higher year over year.
  • Riot Platforms, Inc. (NASDAQ:RIOT) gained 10.3% to $7.78.
  • Coinbase Global, Inc. (NASDAQ:COIN) surged 9.4% to $74.15.
  • XPeng Inc. (NYSE:XPEV) gained 8.2% to $9.02 after the company reported a fourth-quarter FY22 sales decline of 39.9% year-on-year, to RMB5.14 billion ($745.28 million), missing the consensus of $834.05 million.
  • FedEx Corporation (NYSE:FDX) rose 8% to $220.32 after the company reported better-than-expected Q3 EPS and raised its FY23 outlook.
  • Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) jumped 7.4% to $13.57.
  • Baidu, Inc. (NASDAQ:BIDU) gained 6.2% to $146.74 after the company announced it has been granted the first-ever permits to provide fully driverless ride-hailing service in the Chinese capital Beijing.


  • Lifecore Biomedical, Inc. (NASDAQ:LFCR) shares declined 61.6% to $1.9616 after the company reported worse-than-expected Q2 financial results.
  • Diebold Nixdorf, Incorporated (NYSE:DBD) dropped 53.5% to $1.07. Wedbush reiterated Diebold Nixdorf with an Outperform and maintained a $5 price target.
  • Acer Therapeutics Inc. (NASDAQ:ACER) fell 46.4% to $0.8313 after the company announced its Phase 2a trial data showing ACER-801 was safe and well-tolerated but did not achieve statistical significance when evaluating the ability to decrease the frequency or severity of hot flashes in postmenopausal women.
  • Pear Therapeutics, Inc. (NASDAQ:PEAR) declined 44% to $0.33. Pear Therapeutics announced process exploring strategic alternatives.
  • Blend Labs, Inc. (NYSE:BLND) dropped 36.5% to $0.9338 after the company reported worse-than-expected Q4 adjusted EPS and sales results.
  • Nexters Inc. (NASDAQ:GDEV) shares fell 35.7% to $3.60 after the company issued Q4 update.
  • Loyalty Ventures Inc. (NASDAQ:LYLT) dropped 26.8% to $0.1061.
  • First Republic Bank (NYSE:FRC) dropped 26.2% to $25.23 after the bank announced a deal for $30 billion in deposits from major banks and said it has decided to suspend its dividend.
  • Panbela Therapeutics, Inc. (NASDAQ:PBLA) dropped 23.5% to $0.5050 after the company reported worse-than-expected Q4 EPS results.
  • Purple Innovation, Inc. (NASDAQ:PRPL) fell 21.6% to $2.5815 after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 revenue guidance below analyst estimates.
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) dropped 19.9% to $119.83 after the company said that that FDA has decided to hold a public advisory committee meeting on its SRP 9001 BLA.
  • Casa Systems, Inc. (NASDAQ:CASA) fell 19.8% to $1.3950.
  • Reliance Global Group, Inc. (NASDAQ:RELI) fell 19.3% to $3.1299.
  • Montauk Renewables, Inc. (NASDAQ:MNTK) declined 19% to $7.70 after the company reported full year 2022 results.
  • RedHill Biopharma Ltd. (NASDAQ:RDHL) fell 19% to $0.1457. RedHill Biopharma announced plan to implement ADS ratio change from a 1 ADS-for-10 ordinary shares ratio to a 1 ADS-for-400 ordinary share ratio (1-for-40) on or about March 23, 2023.
  • Groupon, Inc. (NASDAQ:GRPN) fell 19% to $3.97 after the company reported worse-than-expected Q4 sales results.
  • Western Alliance Bancorporation (NYSE:WAL) dropped 17.6% to $30.34. Shares of several companies in the broader financial space traded lower on continued downward momentum in the sector amid volatility and stability concerns following multiple bank failures.
  • Impac Mortgage Holdings, Inc. (NYSE:IMH) fell 17.5% to $0.24 after posting a wider quarterly loss.
  • Pharming Group N.V. (NASDAQ:PHAR) fell 17% to $9.94 following Q4 results.
  • Semantix, Inc. (NASDAQ:STIX) dropped 16.8% to $ 3.7250.
  • CareMax, Inc. (NASDAQ:CMAX) fell 16.6% to $3.0350. CareMax said it sees FY22 revenue of $631.1 million.
  • Karooooo Ltd. (NASDAQ:KARO) dipped 15.8% to $22.00.
  • OncoCyte Corporation (NASDAQ:OCX) fell 15% to $0.2574.
  • Aspen Aerogels, Inc. (NYSE:ASPN) dropped 14.7% to $6.67.
  • Dermata Therapeutics, Inc. (NASDAQ:DRMA) fell 14% to $1.90.
  • PacWest Bancorp (NASDAQ:PACW) fell 13.3% to $ 9.93.
  • Sunnova Energy International Inc. (NYSE:NOVA) fell 14.4% to $12.59.
  • Emergent BioSolutions Inc. (NYSE:EBS) dropped 12.8% to $8.41 after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $23 to $9.
  • Cutera, Inc. (NASDAQ:CUTR) fell 11.1% to $24.75.
  • Sunrun Inc. (NASDAQ:RUN) dropped 10% to $17.10.
  • Metropolitan Bank Holding Corp. (NYSE:MCB) fell 10% to $35.81.
  • SL Green Realty Corp. (NYSE:SLG) dropped 9.6% to $23.77.
  •, Corp. (NYSE:DESP) fell 9.2% to $5.01. recently posted downbeat quarterly results.
  • Design Therapeutics, Inc. (NASDAQ:DSGN) dropped 8.8% to $6.41.

Now Read This: Top 5 Tech Stocks Which You’ll Regret Missing This Quarter